First Financial Corp’s Juno Therapeutics, Inc. JUNO Stock Holding History

First Financial Corp’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-250	Closed	-$11K	–	362
2017 Q4	$11K	Buy	250 +50	+25%	+$2.49K	0.01%	329
2017 Q3	$9K	Buy	+200	New	+$6.82K	0.01%	346
2017 Q2	–	Sell	-500	Closed	-$11K	–	412
2017 Q1	$11K	Hold	500	–	–	0.01%	356
2016 Q4	$9K	Hold	500	–	–	0.01%	360
2016 Q3	$15K	Hold	500	–	–	0.01%	333
2016 Q2	$19K	Buy	500 +100	+25%	+$4.15K	0.01%	337
2016 Q1	$15K	Buy	400 +100	+33%	+$3.48K	0.01%	356
2015 Q4	$13K	Buy	300 +150	+100%	+$7.44K	0.01%	369
2015 Q3	$6K	Buy	+150	New	+$6.58K	﹤0.01%	421

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

First Financial Corp's JUNO Position: Q1 2018 in Review

First Financial Corp sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 250 shares — an estimated $11K sold.

First Financial Corp first reported a position in JUNO in Q3 2015 and held it in 9 quarters. The position peaked at $19K in Q2 2016. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

First Financial Corp reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
First Financial Corp sold 250 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $11K.
First Financial Corp first reported a position in Juno Therapeutics, Inc. in Q3 2015 and held it in 9 quarters.
First Financial Corp's Juno Therapeutics, Inc. position peaked at $19K in Q2 2016.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on First Financial Corp's 13F filing for Q1 2018, filed 17 Apr 2018.